Torthaí cuardaigh - Jyun-Yan Yang

  • 1 - 3 toradh as 3 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

    Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial de réir Vladimir Skljarevski, Manjit Matharu, Brian A. Millen, Michael H. Ossipov, Byung‐Kun Kim, Jyun Yan Yang

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment

    Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment de réir David W. Dodick, Peter J. Goadsby, Christian Lucas, Rigmor Jensen, Jennifer Bardos, James M. Martinez, Chunmei Zhou, Sheena K. Aurora, Jyun Yan Yang, Robert R. Conley, Tina M. Oakes

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Trial of Galcanezumab in Prevention of Episodic Cluster Headache

    Trial of Galcanezumab in Prevention of Episodic Cluster Headache de réir Peter J. Goadsby, David W. Dodick, Massimo Leone, Jennifer Bardos, Tina M. Oakes, Brian A. Millen, Chunmei Zhou, Sherie A. Dowsett, Sheena K. Aurora, Andrew H. Ahn, Jyun-Yan Yang, Robert R. Conley, James M. Martinez

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: